Ceragon earnings beat by $0.07, revenue topped estimates

Ceragon (NASDAQ: CRNT ) reported third quarter EPS of $0.160, $0.07 better than the analyst estimate of $0.090. Revenue for the quarter came in at $102.7M versus the consensus estimate of $102.61M. Guidance



Ceragon sees FY 2024 revenue of $390.000M-$400.000M versus the analyst consensus of $392.400M.





Ceragon's stock price closed at $2.56. It is down -11.110% in the last 3 months and up 45.450% in the last 12 months.

Ceragon saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Ceragon's stock price’s past reactions to earnings here.

According to InvestingPro, Ceragon's Financial Health score is "great performance".

Check out Ceragon's recent earnings performance , and Ceragon's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Source: Investing.com